Dexamethasone (Dekort 4 mg) and Imatinib: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Systemic dexamethasone can induce CYP3A metabolism and lower imatinib exposure.
Clinical significance and safety
Dekort 4 mg contains dexamethasone, specifically listed among enzyme-inducing medicines in GLEEVEC labeling. Relevance depends on the steroid regimen and duration, so the cancer team should assess whether treatment exposure could be reduced. Do not stop a corticosteroid abruptly or change cancer treatment independently.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.